A detailed history of Franklin Resources Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 13,873,744 shares of ABBV stock, worth $2.47 Billion. This represents 0.82% of its overall portfolio holdings.

Number of Shares
13,873,744
Previous 14,678,884 5.49%
Holding current value
$2.47 Billion
Previous $2.9 Billion 5.49%
% of portfolio
0.82%
Previous 0.84%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 27, 2024

SELL
$163.84 - $199.33 $132 Million - $160 Million
-805,140 Reduced 5.49%
13,873,744 $2.74 Billion
Q3 2024

Nov 12, 2024

SELL
$163.84 - $199.33 $209 Million - $254 Million
-1,275,651 Reduced 8.0%
14,678,884 $2.9 Billion
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $744 Million - $869 Million
4,808,188 Added 43.14%
15,954,535 $2.74 Billion
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $571 Million - $651 Million
3,575,662 Added 47.23%
11,146,347 $2.03 Billion
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $46.6 Million - $52.5 Million
338,789 Added 4.68%
7,570,685 $1.17 Billion
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $14.8 Million - $17.1 Million
110,691 Added 1.55%
7,231,896 $1.08 Billion
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $127 Million - $159 Million
-961,754 Reduced 11.9%
7,121,205 $959 Million
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $396 Million - $456 Million
-2,736,893 Reduced 25.3%
8,082,959 $1.29 Billion
Q4 2022

Feb 10, 2023

SELL
$138.31 - $165.87 $139 Million - $166 Million
-1,003,268 Reduced 8.49%
10,819,852 $1.75 Billion
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $134 Million - $154 Million
-998,615 Reduced 7.79%
11,823,120 $1.59 Billion
Q2 2022

Aug 11, 2022

SELL
$137.62 - $174.96 $185 Million - $236 Million
-1,346,574 Reduced 9.5%
12,821,735 $1.96 Billion
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $746 Million - $925 Million
-5,648,748 Reduced 28.5%
14,168,309 $2.3 Billion
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $349 Million - $442 Million
3,249,849 Added 19.62%
19,817,057 $2.68 Billion
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $8.1 Million - $9.2 Million
-76,159 Reduced 0.46%
16,567,208 $1.79 Billion
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $775 Million - $864 Million
7,370,931 Added 79.49%
16,643,367 $1.87 Billion
Q1 2021

May 13, 2021

BUY
$102.3 - $112.62 $462 Million - $509 Million
4,517,035 Added 94.99%
9,272,436 $1 Billion
Q4 2020

Feb 10, 2021

SELL
$80.49 - $108.67 $95.9 Million - $130 Million
-1,191,805 Reduced 20.04%
4,755,401 $510 Million
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $77 Million - $90.3 Million
-895,784 Reduced 13.09%
5,947,206 $521 Million
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $205 Million - $274 Million
2,789,463 Added 68.82%
6,842,990 $669 Million
Q1 2020

May 13, 2020

BUY
$64.5 - $97.79 $17,673 - $26,794
274 Added 0.01%
4,053,527 $309 Million
Q4 2019

Feb 12, 2020

BUY
$72.13 - $90.25 $5.58 Million - $6.98 Million
77,314 Added 1.94%
4,053,253 $359 Million
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $149 Million - $179 Million
-2,362,468 Reduced 37.27%
3,975,939 $301 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $135 Million - $173 Million
2,060,033 Added 48.15%
6,338,407 $461 Million
Q1 2019

May 14, 2019

BUY
$77.14 - $90.79 $472,173 - $555,725
6,121 Added 0.14%
4,278,374 $345 Million
Q4 2018

Feb 12, 2019

BUY
$77.85 - $96.01 $9.78 Million - $12.1 Million
125,596 Added 3.03%
4,272,253 $394 Million
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $24.4 Million - $27.2 Million
-274,846 Reduced 6.22%
4,146,657 $392 Million
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $5.55 Million - $6.57 Million
61,838 Added 1.42%
4,421,503 $410 Million
Q1 2018

May 10, 2018

BUY
$92.01 - $123.21 $31.3 Million - $42 Million
340,709 Added 8.48%
4,359,665 $413 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $15.3 Million - $16.8 Million
-170,964 Reduced 4.08%
4,018,956 $389 Million
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $293 Million - $374 Million
4,189,920
4,189,920 $372 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.